Antios Therapeutics Inc. — Form D
Antios Therapeutics Inc. of MENDHAM, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-05. The offering totals $25.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-05
- Form: D
- Accession: 0000910680-18-000082
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $15.0M
- Remaining: $10.0M
- Investors: 10
- Date of first sale: 2018-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-327214
Issuer
- Name: Antios Therapeutics Inc.
- CIK: 0001760428
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 HORSESHOE BEND ROAD, MENDHAM, NJ, 07945
- Phone: 215-696-9659
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Nicole Vitulio | Director | Atlanta, GA |
| Gregory Mayes | Director | Morristown, NJ |
| Gregory Mayes | Executive Officer | Morristown, NJ |
| Idean Marvasty | Executive Officer | Atlanta, GA |
| CRAIG GORDON | Director | NOVATO, CA |
| DAVID CANNER | Director | SEATTLE, WA |
| Henry Lin Chen | Director | GRAND CAYMAN, E9 |
| Benjamin Rovinski | Director | Mendham, NJ |
| Scott Morenstein | Director | Mendham, NJ |
| Tamra Adams | Executive Officer | Mendham, NJ |
| Abel De La Rosa | Director | Philadelphia, PA |
| Abel De La Rosa | Executive Officer | Philadelphia, PA |
| Douglas Mayers | Executive Officer | Mendham, NJ |
| Patrick Higgins | Director | Philadelphia, PA |
| Iyona Rajkomar | Director | Mendham, NJ |
| Douglas Lin Mayers | Executive Officer | Atlanta, GA |
| Nicole Vitullo | Director | Atlanta, GA |
Other filings by this issuer (3)
More